TipRanks on MSN

Tandem Diabetes price target raised to $17 from $13 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Tandem Diabetes (TNDM) to $17 from $13 and keeps an Equal Weight rating on the shares. Published ...